Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Terence Moyana"'
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 5, Iss , Pp 100144- (2022)
Background: Acinar cell carcinoma of the pancreas (ACC) is a rare malignancy, accounting for approximately 1-2% of all pancreatic cancers. Up to a quarter of ACCs are estimated to contain a significant component of another histology such as neuroendo
Externí odkaz:
https://doaj.org/article/23c073c07f704e82a3f3d0d32393e92b
Publikováno v:
Canadian Respiratory Journal, Vol 21, Iss 4, Pp 211-212 (2014)
Externí odkaz:
https://doaj.org/article/fb0b236278f84028a1c683899f2a579b
Publikováno v:
Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes. 71(4)
Gallbladder cancer is an uncommon malignancy with an overall poor prognosis. The clinical and imaging presentation of gallbladder cancer often overlaps with benign disease, making diagnosis difficult. Gallbladder cancer is most easily diagnosed on im
Autor:
Guillaume Martel, Goo Lee, Mario Capitano, D Blair Macdonald, Terence Moyana, Sergey Pyatibrat
Publikováno v:
Journal of Pancreatic Cancer, Vol 3, Iss 1, Pp 71-77 (2017)
Journal of Pancreatic Cancer
Journal of Pancreatic Cancer
Purpose: To investigate the association between pancreatic neuroendocrine tumors (panNETs) and sinistral portal hypertension (SPH) and provide insights into the pathogenesis. Methods: A retrospective review of panNETs was conducted from our instituti
Autor:
Wayne S. Kendal, Avijit Chatterjee, Shaheed W. Hakim, Richard Mimeault, Derek J. Jonker, Wael Shabana, Terence Moyana, Laval Grimard, Jean A. Maroun
Publikováno v:
Archives of Pathology & Laboratory Medicine. 138:896-902
Context.—Pancreatic neuroendocrine tumors (Panc-NETs) are rare and tend to get overshadowed by their more prevalent and aggressive ductal adenocarcinoma counterparts. The biological behavior of PancNETs is unpredictable, and thus management is cont
Publikováno v:
BMC Cancer
Background Pancreatic cancer is among the top 5 most common cancers worldwide, but is particularly devastating due to its insidious nature. Complete surgical resection remains the only potential curative treatment, although only 20 % of patients pres
Autor:
Nirit Yarom, Horia Marginean, Celia Marginean, Ivan Gorn-Hondermann, Micheal Vickers, H. Chaim Birnboim, Rebecca C. Auer, Timothy R. Asmis, Terence Moyana, Jean A. Maroun, Derek J. Jonker
Publikováno v:
Cancer Biology & Therapy. 10:416-421
Previous studies indicate that drugs targeting the Epidermal Growth Factor Receptor (EGFR) signaling pathways can induce objective responses, prolong time to progression and improve survival of patients with metastatic colorectal cancer (mCRC). EGFR
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 22:692-703
Exosomes (EXOs) are nanometer-sized membrane vesicles secreted from epithelial and hematopoietic cells. They display a spectrum of molecules involved in immune responses and signal transductions. Previous studies showed that tumor antigen-loaded dend
Autor:
Jim Xiang, Xiaochu Wu, Zhenmin Ye, Terence Moyana, Yangdou Wei, Chaoke Tang, Yongqing Liu, Tianpei He
Publikováno v:
Biochemical and Biophysical Research Communications. 359:202-208
The acquisition of dendritic cell (DC) molecules by T cells has been previously reported. However, it remains unclear whether the transfer is only mono- or bidirectional. In this study, we incubated CMFDA-labeled ovalbumin (OVA)-pulsed DC2.4 (DC2.4(O
Publikováno v:
Cell Research. 16:241-259
Recent developments in tumor immunology and biotechnology have made cancer gene therapy and immunotherapy feasible. The current efforts for cancer gene therapy mainly focus on using immunogenes, chemogenes and tumor suppressor genes. Central to all t